These studies were conducted on a multi-institutional cohort, comprising 711 human subjects, and they showed that flouresence in situ hybridization (FISH) for AURKA copy number performed on cells from voided urine, can be used for the non-invasive detection and monitoring of bladder cancer. The gene discussed is AURKA; the disease is urinary bladder cancer.